Invest Stockholm is delighted to welcome you to the launch event for our new report. Why are leading life science companies and rapidly expanding startups from around the globe increasingly putting down roots in the Stockholm-Uppsala region? Invest Stockholm's brand new report shines a light on an entrepreneurial culture of innovation in Scandinavia's leading life science cluster, where close ties between government, industry and academia facilitate the development of ideas into commercially viable products.
Opinion leaders Johan Rockberg, KTH and Catarina Flyborg, Cytiva, will give us their expert perspectives on the thriving cluster, and we are also very much looking forward to presenting success stories from AstraZeneca, Cambrex and Valneva.
For more information and registration click here.
